The Pathogenesis, Treatment, and Possible Prevention of Uremic Bone Disease
Uremic bone disease can be classified into three major types based on histomorphometric analysis of double tetracycline labeling of iliac crest bone obtained by trephine (Table I). Type I consists of patients with high-turnover bone disease. Type II consists of patients with high-turnover bone disease in which the major manifestation of the abnormal mineral metabolism associated with uremia is metastatic calcification. Type III consists of patients with low turnover bone disease.
KeywordsParathyroid Hormone Bone Disease Skeletal Defect Marrow Fibrosis Metastatic Calcification
Unable to display preview. Download preview PDF.
- 1.Coburn JW, Massry SG (eds): Uses and actions of 1,25(OH)2D3 in uremia. Contrib Nephrol 18:1–217, 1980.Google Scholar
- 3.Massry SG, Coburn JW: Divalent ion metabolism and renal osteodystrophy, in Massry SG, Sellers AL (eds): Clinical Aspects of Uremia and Dialysis. Springfield, Ill, Charles C Thomas, 1976, pp 304–399.Google Scholar